The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Reminyl XL 8 mg prolonged-release capsules, hard

8 milligram(s) Prolonged-release capsule

PCO Manufacturing Ltd.PPA0465/166/002

Main Information

Trade NameReminyl XL 8 mg prolonged-release capsules, hard
Active SubstancesGalantamine
Strength8 milligram(s)
Dosage FormProlonged-release capsule
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/166/002

Group Information

ATC CodeN06DA Anticholinesterases
N06DA04 galantamine

Status

Authorised/WithdrawnAuthorised
Licence Issued25/09/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA0535/006/005.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back